Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by ledrogon Aug 20, 2018 9:23pm
134 Views
Post# 28490237

Short interest drops to 657,102

Short interest drops to 657,102

That's up to Aug 15th, and its a drop of 185,317.....and this includes the trading that took place after the US/Rothschild listing news which came out after the bell on July 31st, and then the 7th thumbs up from the DSMB.

So we have seen some short covering, but there's still work to do if shorts want to reduce their exposure to where it was at before the proposed (and subequently cancelled) share offering.

Short Positions for RVX
Symbol Report Date Volume Change Shares Issued % Float
T : RVX 2018-08-15 657,102 -185,317 177,257,625 0.37
T : RVX 2018-07-31 842,419 -73,654 177,257,625 0.48
T : RVX 2018-07-15 916,073 -364,495 177,185,992 0.52
T : RVX 2018-06-30 1,280,568 -357,943 177,185,992 0.72
T : RVX 2018-06-15 1,638,511 -16,821 177,185,992 0.92
T : RVX 2018-05-31 1,655,332 507,940 177,185,992 0.93
T : RVX 2018-05-15 1,147,392 -44,041 177,181,992 0.65
T : RVX 2018-04-30 1,191,433 1,015,228 177,181,992 0.67
T : RVX 2018-04-15 176,205 -10,477 176,817,078 0.10

Bullboard Posts